
Facebook has a message for regulators and policy makers concerned about the company’s harvesting of user information: don’t treat data as a simple resource like oil.
Nick Clegg, Facebook’s vice president of global affairs and communications, said Monday that antitrust officials should be careful not to treat data like other commodities that could be monopolized, but rather as something more complex that can be shared and kept at the same time.
“We think it is legitimate to ask profound questions about how data is held,” Mr. Clegg said at a briefing with journalists on Monday. But he added that officials defining what he called the orthodoxy of competition policy should “reconfigure old concepts” and “relinquish themselves of the idea that [using data] is the same as using finite resources in finite, one-off ways.”
Mr. Clegg’s statement comes as tech companies including Facebook and Alphabet Google face growing antitrust scrutiny on both sides of the Atlantic for their control and use of user data. In the US, both the Justice Department and Federal Trade Commission are probing the companies.
The European Commission, the European Union’s antitrust enforcer, is also in the early stages of probes into how both Google and Facebook gather and monetize data about their users for advertising purposes, according to a commission spokeswoman.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas